Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Biochip technology for the serological diagnosis of bullous pemphigoid.

Zarian H, Saponeri A, Michelotto A, Zattra E, Belloni-Fortina A, Alaibac M.

ISRN Dermatol. 2012;2012:237802. doi: 10.5402/2012/237802. Epub 2012 Dec 17.

2.

Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles.

Tanaka M, Hashimoto T, Dykes PJ, Nishikawa T.

Clin Exp Dermatol. 1996 Jan;21(1):23-7.

PMID:
8689764
3.

Serological diagnosis of autoimmune bullous skin diseases: prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy.

van Beek N, Rentzsch K, Probst C, Komorowski L, Kasperkiewicz M, Fechner K, Bloecker IM, Zillikens D, Stöcker W, Schmidt E.

Orphanet J Rare Dis. 2012 Aug 9;7:49. doi: 10.1186/1750-1172-7-49.

4.

Evaluation of a BP180-NC16a enzyme-linked immunosorbent assay in the initial diagnosis of bullous pemphigoid.

Sakuma-Oyama Y, Powell AM, Oyama N, Albert S, Bhogal BS, Black MM.

Br J Dermatol. 2004 Jul;151(1):126-31.

PMID:
15270881
5.

Prevalence of pemphigus and pemphigoid autoantibodies in the general population.

Prüßmann W, Prüßmann J, Koga H, Recke A, Iwata H, Juhl D, Görg S, Henschler R, Hashimoto T, Schmidt E, Zillikens D, Ibrahim SM, Ludwig RJ.

Orphanet J Rare Dis. 2015 May 15;10:63. doi: 10.1186/s13023-015-0278-x.

6.

Place of human amniotic membrane immunoblotting in the diagnosis of autoimmune bullous dermatoses.

Grootenboer-Mignot S, Descamps V, Picard-Dahan C, Nicaise-Roland P, Prost-Squarcioni C, Leroux-Villet C, Champagnat C, Delaval A, Aucouturier F, Crickx B, Chollet-Martin S.

Br J Dermatol. 2010 Apr;162(4):743-50. doi: 10.1111/j.1365-2133.2009.09566.x. Epub 2009 Nov 3.

PMID:
19886889
7.

Autoantibody detection in bullous pemphigoid: clinical evaluation of the EUROPLUS™ Dermatology Mosaic.

Damoiseaux J, van Rijsingen M, Warnemünde N, Dähnrich C, Fechner K, Tervaert JW.

J Immunol Methods. 2012 Aug 31;382(1-2):76-80. doi: 10.1016/j.jim.2012.05.007. Epub 2012 May 9.

PMID:
22580378
8.

Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies.

Sitaru C, Dähnrich C, Probst C, Komorowski L, Blöcker I, Schmidt E, Schlumberger W, Rose C, Stöcker W, Zillikens D.

Exp Dermatol. 2007 Sep;16(9):770-7.

PMID:
17697150
9.
10.

Epitope mapping of BP230 leading to a novel enzyme-linked immunosorbent assay for autoantibodies in bullous pemphigoid.

Blöcker IM, Dähnrich C, Probst C, Komorowski L, Saschenbrecker S, Schlumberger W, Stöcker W, Zillikens D, Schmidt E.

Br J Dermatol. 2012 May;166(5):964-70. doi: 10.1111/j.1365-2133.2012.10820.x. Epub 2012 Apr 4.

PMID:
22242606
11.

Autoantibodies to basement membrane proteins BP180 and BP230 are commonly detected in normal subjects by immunoblotting.

Desai N, Allen J, Ali I, Venning V, Wojnarowska F.

Australas J Dermatol. 2008 Aug;49(3):137-41. doi: 10.1111/j.1440-0960.2008.00452.x.

PMID:
18638220
12.

Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients.

Mariotti F, Grosso F, Terracina M, Ruffelli M, Cordiali-Fei P, Sera F, Zambruno G, Mastrogiacomo A, Di Zenzo G.

Br J Dermatol. 2004 Nov;151(5):1004-10.

PMID:
15541078
13.

Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid.

Di Zenzo G, Thoma-Uszynski S, Fontao L, Calabresi V, Hofmann SC, Hellmark T, Sebbag N, Pedicelli C, Sera F, Lacour JP, Wieslander J, Bruckner-Tuderman L, Borradori L, Zambruno G, Hertl M.

Clin Immunol. 2008 Sep;128(3):415-26. doi: 10.1016/j.clim.2008.04.012. Epub 2008 Jun 20.

PMID:
18571472
14.

Bullous pemphigoid: serum antibody titre and antigen specificity.

Pas HH, de Jong MC, Jonkman MF, Heeres K, Slijper-Pal IJ, van der Meer JB.

Exp Dermatol. 1995 Dec;4(6):372-6.

PMID:
8608345
15.

Usefulness of Enzyme-linked Immunosorbent Assay Using Recombinant BP180 and BP230 for Serodiagnosis and Monitoring Disease Activity of Bullous Pemphigoid.

Lee EH, Kim YH, Kim S, Kim SE, Kim SC.

Ann Dermatol. 2012 Feb;24(1):45-55. doi: 10.5021/ad.2012.24.1.45. Epub 2012 Feb 2.

16.

Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid.

Schmidt E, Obe K, Bröcker EB, Zillikens D.

Arch Dermatol. 2000 Feb;136(2):174-8.

PMID:
10677092
17.

Detection of linear IgE deposits in bullous pemphigoid and mucous membrane pemphigoid: a useful clue for diagnosis.

Yayli S, Pelivani N, Beltraminelli H, Wirthmüller U, Beleznay Z, Horn M, Borradori L.

Br J Dermatol. 2011 Nov;165(5):1133-7. doi: 10.1111/j.1365-2133.2011.10481.x.

PMID:
21711326
18.

Relapse-associated autoantibodies to BP180 in a patient with anti-p200 pemphigoid.

Kasperkiewicz M, Hoppe U, Zillikens D, Schmidt E.

Clin Exp Dermatol. 2010 Aug;35(6):614-7. doi: 10.1111/j.1365-2230.2009.03731.x. Epub 2009 Oct 23.

PMID:
19874345
19.

Prevalence and clinical significance of anti-laminin 332 autoantibodies detected by a novel enzyme-linked immunosorbent assay in mucous membrane pemphigoid.

Bernard P, Antonicelli F, Bedane C, Joly P, Le Roux-Villet C, Duvert-Lehembre S, Rousselle P, Prost-Squarcioni C.

JAMA Dermatol. 2013 May;149(5):533-40. doi: 10.1001/jamadermatol.2013.1434.

PMID:
23426192
20.

Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid.

Iwata Y, Komura K, Kodera M, Usuda T, Yokoyama Y, Hara T, Muroi E, Ogawa F, Takenaka M, Sato S.

Arch Dermatol. 2008 Jan;144(1):41-8. doi: 10.1001/archdermatol.2007.9.

PMID:
18209167

Supplemental Content

Support Center